123402-03-9

Upstream product

• 188444-26-0 Methyl (4S,5E)-8-(4-chlorophenylselenenyl)-4-(4-methoxybenzylthio)-2,4,6-trimethyl-3-oxooct-5-enoate 
• 123401-99-0 1-<(2S,3E)-6-(4-Chlorophenylselenenyl)-2,4-dimethyl-2-(4-methoxybenzylthio)hex-3-enoyl>imidazole 
• 123430-69-3 Ethyl (2S,3E)-6-(4-chlorophenylseleno)-2,4-dimethyl-2-(4-methoxybenzylthio)hex-3-enoate 
• 188443-95-0 (2S,3E)-6-(4-Chlorophenylselenenyl)-2,4-dimethyl-2-(4-methoxybenzylthio)hex-3-enoic acid 
• 123430-68-2 Ethyl (2S,3E)-2,4-dimethyl-6-hydroxy-2-(4-methoxybenzylthio)hex-3-enoate 
• 123401-96-7 Ethyl (2S,3E)-4-formyl-2-(4-methoxybenzylthio)-2-methylpent-3-enoate 
• 123401-98-9 Ethyl (2S,3E)-2,4-dimethyl-2-(4-methoxybenzylthio)hexa-3,5-dienoate 
• 188444-27-1 (E)-(S)-8-(4-Chloro-phenylselanyl)-4-mercapto-2,4,6-trimethyl-3-oxo-oct-5-enoic acid methyl ester 

Relevant academic research and scientific papers

Asymmetric synthesis of 5,5-disubstituted thiotetronic acids using an allyl xanthate to dithiocarbonate rearrangement: Total synthesis of (55)-thiolactomycin with revision of the absolute configuration of the natural product

An asymmetric synthesis of thiotetronic acids related to the antibiotics thiolactomycin 1 and thiotetromycin 2 has been developed in which the key step is a stereoselective [3.3]-rearrangement of an allyl xanthate to the corresponding dithiocarbonate. Thu